0001748137 2024-07-01 2025-06-30 0001748137 NEOV:CommonStockParValue0.001PerShareMember 2024-07-01 2025-06-30 0001748137 NEOV:WarrantsEachWarrantExercisableForOneShareOfCommonStockMember 2024-07-01 2025-06-30 0001748137 2024-12-31 0001748137 2025-09-26 0001748137 2025-06-30 0001748137 2024-06-30 0001748137 2023-07-01 2024-06-30 0001748137 us-gaap:CommonStockMember 2023-06-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001748137 us-gaap:RetainedEarningsMember 2023-06-30 0001748137 2023-06-30 0001748137 us-gaap:CommonStockMember 2024-06-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001748137 us-gaap:RetainedEarningsMember 2024-06-30 0001748137 us-gaap:CommonStockMember 2023-07-01 2024-06-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2024-06-30 0001748137 us-gaap:RetainedEarningsMember 2023-07-01 2024-06-30 0001748137 us-gaap:CommonStockMember 2024-07-01 2025-06-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2025-06-30 0001748137 us-gaap:RetainedEarningsMember 2024-07-01 2025-06-30 0001748137 us-gaap:CommonStockMember 2025-06-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001748137 us-gaap:RetainedEarningsMember 2025-06-30 0001748137 NEOV:DealerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-07-01 2025-06-30 0001748137 NEOV:DealerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-07-01 2025-06-30 0001748137 NEOV:DealerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-07-01 2025-06-30 0001748137 NEOV:DealerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-07-01 2025-06-30 0001748137 NEOV:DealerThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-07-01 2025-06-30 0001748137 NEOV:DealerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2024-06-30 0001748137 NEOV:DealerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2024-06-30 0001748137 NEOV:RestrictedStockUnitsMember 2024-07-01 2025-06-30 0001748137 NEOV:InvestorWarrantsMember 2024-07-01 2025-06-30 0001748137 NEOV:RestrictedStockUnitsForAnOfficerMember 2024-07-01 2025-06-30 0001748137 2024-09-03 0001748137 2024-09-01 2024-09-03 0001748137 NEOV:CommercialLenderMember 2024-10-03 2024-10-04 0001748137 NEOV:CommercialLenderMember 2024-11-30 0001748137 NEOV:CommercialLenderMember 2024-07-01 2025-06-30 0001748137 NEOV:CommercialLenderMember 2025-06-30 0001748137 NEOV:PrivateEquityOfferingMember 2025-02-28 0001748137 NEOV:PrivateEquityOfferingMember 2025-02-01 2025-02-28 0001748137 NEOV:UnderwrittenPublicOfferingMember 2022-08-01 2022-08-31 0001748137 NEOV:UnitsMember NEOV:UnderwrittenPublicOfferingMember 2022-08-01 2022-08-31 0001748137 NEOV:UnderwriterMember NEOV:UnderwrittenPublicOfferingMember 2022-08-01 2022-08-31 0001748137 NEOV:UnderwriterMember NEOV:UnderwrittenPublicOfferingMember 2022-08-31 0001748137 NEOV:ConvertibleNotes2018Member NEOV:UnderwrittenPublicOfferingMember 2022-08-01 2022-08-31 0001748137 NEOV:ConvertibleNotes2021Member NEOV:UnderwrittenPublicOfferingMember 2022-08-01 2022-08-31 0001748137 NEOV:WarrantsMember 2024-11-01 2024-11-30 0001748137 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember 2024-04-01 2024-04-30 0001748137 srt:ChiefFinancialOfficerMember us-gaap:RestrictedStockUnitsRSUMember 2025-02-01 2025-02-28 0001748137 srt:ChiefFinancialOfficerMember us-gaap:RestrictedStockUnitsRSUMember 2022-02-01 2022-02-28 0001748137 srt:ChiefFinancialOfficerMember us-gaap:RestrictedStockUnitsRSUMember NEOV:Milestone1Member 2022-12-30 2023-01-02 0001748137 srt:ChiefFinancialOfficerMember us-gaap:RestrictedStockUnitsRSUMember NEOV:Milestone2Member 2023-12-30 2024-01-02 0001748137 srt:ChiefOperatingOfficerMember us-gaap:RestrictedStockUnitsRSUMember 2025-01-01 2025-01-31 0001748137 NEOV:TwoOtherIndividualsMember us-gaap:RestrictedStockUnitsRSUMember 2024-06-01 2024-06-30 0001748137 NEOV:TwoOtherIndividualsMember us-gaap:RestrictedStockUnitsRSUMember 2024-10-01 2024-10-31 0001748137 NEOV:ThreeOfficersAndTwoOtherIndividualsMember us-gaap:RestrictedStockUnitsRSUMember 2025-01-01 2025-01-31 0001748137 NEOV:ThreeOfficersAndTwoOtherIndividualsMember us-gaap:RestrictedStockUnitsRSUMember 2024-07-01 2025-06-30 0001748137 NEOV:ThreeOfficersAndTwoOtherIndividualsMember us-gaap:RestrictedStockUnitsRSUMember 2023-07-01 2024-06-30 0001748137 NEOV:TwoDirectorsMember 2025-06-30 0001748137 NEOV:AmortizedValueOfRSUsMember 2024-07-01 2025-06-30 0001748137 NEOV:NewCompensationPlanMember 2024-07-01 2025-06-30 0001748137 NEOV:IssuanceOfSharesForAdvisoryServicesMember 2024-07-01 2025-06-30 0001748137 NEOV:AmortizedValueOfCompensationPlanMember 2024-07-01 2025-06-30 0001748137 NEOV:IssuanceOfSharesForConsultingAndMarketingServicesMember 2024-07-01 2025-06-30 0001748137 NEOV:VariousGranteesMember 2024-07-01 2025-06-30 0001748137 NEOV:VariousGranteesMember NEOV:RecognizedInPriorYearMember 2024-07-01 2025-06-30 0001748137 NEOV:AmortizedValueOfRSUsMember 2023-07-01 2024-06-30 0001748137 NEOV:AmortizedValueOfCompensationPlanMember 2023-07-01 2024-06-30 0001748137 NEOV:AmortizedValueOfSharesGrantedMember 2023-07-01 2024-06-30 0001748137 NEOV:FairValueOfIncentiveSharesMember 2023-07-01 2024-06-30 0001748137 NEOV:IndependentDirectorsMember 2023-07-01 2024-06-30 0001748137 NEOV:StockPlan2019Member 2019-02-28 0001748137 NEOV:StockPlan2019Member 2024-12-31 0001748137 NEOV:StockPlan2019Member 2024-07-01 2025-06-30 0001748137 NEOV:ThreeExecutiveOfficersAndNonExecutiveMember us-gaap:RestrictedStockUnitsRSUMember NEOV:StockPlan2019Member 2024-07-01 2025-06-30 0001748137 NEOV:ThreeIndependentDirectorsMember us-gaap:RestrictedStockUnitsRSUMember NEOV:StockPlan2019Member 2024-07-01 2025-06-30 0001748137 NEOV:SeveralWholesaleDealersMember us-gaap:RestrictedStockUnitsRSUMember NEOV:StockPlan2019Member 2024-07-01 2025-06-30 0001748137 NEOV:WarrantsMember 2023-06-30 0001748137 NEOV:WarrantsMember 2023-07-01 2024-06-30 0001748137 NEOV:WarrantsMember 2024-06-30 0001748137 NEOV:WarrantsMember 2024-07-01 2025-06-30 0001748137 NEOV:WarrantsMember 2025-06-30 0001748137 2021-01-01 2024-12-31 0001748137 2025-01-01 2025-02-28 0001748137 2025-04-01 2025-06-30 iso4217:USD shares iso4217:USD shares pure false 2025 FY 0001748137 10-K true 2025-06-30 --06-30 false 001-41447 NeoVolta, Inc. NV 82-5299263 12195 Dearborn Place Poway CA 92064 800 364-5464 Common Stock, par value $0.001 per share NEOV NASDAQ Warrants, each warrant exercisable for one share of common stock NEOVW NASDAQ No No Yes Yes Non-accelerated Filer true true false false false false 147900000 34213838 <b><i>Risk Management and Strategy</i></b><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Due to our small size, we have not established formal policies and procedures for assessing, identifying, and managing material risk from cybersecurity threats. However, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90A_ecyd--CybersecurityRiskManagementProcessesIntegratedTextBlock_c20240701__20250630_z9Oy7iZCAZla">we monitor cybersecurity threats internally, including any potential unauthorized occurrence on or conducted through our information systems that we use through third party providers that may result in adverse effects on the confidentiality, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_908_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20240701__20250630_zqmCHhqSDkNf">integrity</span>, or availability of our information systems or any information residing therein.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We conduct annual risk assessments and perform as needed updates to our risks to identify cybersecurity threats, as well as assessments in the event of a material change in our business practices that may affect information systems that are vulnerable to such cybersecurity threats. We do not engage consultants, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_907_ecyd--CybersecurityRiskManagementThirdPartyEngagedFlag_dbF_c20240701__20250630_zCFNA2Uq9nua">third parties</span> and auditors in connection with our risk assessment processes.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_904_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_c20240701__20250630_zJ9MmoxQDgyi">As of June 30, 2025, and through the date of the filing of this report, we are <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_905_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbF_c20240701__20250630_z9X0FrhYZSU2">not</span> aware of any cybersecurity incidents that have materially affected or are reasonably likely to materially affect us, including our business strategy, results of operations or financial condition. </span></p> we monitor cybersecurity threats internally, including any potential unauthorized occurrence on or conducted through our information systems that we use through third party providers that may result in adverse effects on the confidentiality, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_908_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20240701__20250630_zqmCHhqSDkNf">integrity</span>, or availability of our information systems or any information residing therein. true false As of June 30, 2025, and through the date of the filing of this report, we are <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_905_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbF_c20240701__20250630_z9X0FrhYZSU2">not</span> aware of any cybersecurity incidents that have materially affected or are reasonably likely to materially affect us, including our business strategy, results of operations or financial condition.  false <b><i>Governance</i></b><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90A_ecyd--CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20240701__20250630_zulgn0VmlsHi">One of the key responsibilities of our board of directors is informed oversight of our risk management process, including risks from cybersecurity threats. Our board of directors is responsible for monitoring and assessing strategic risk exposure, and our executive officers are responsible for the day-to-day management of the material risks we face and are responsible for reporting to our board of directors any cybersecurity incidents.</span></p><div><div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> </p></div></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_903_ecyd--CybersecurityRiskRoleOfManagementTextBlock_c20240701__20250630_zLzmhf41vWV7">At present, our three executive officers have no particular experience or training in cybersecurity matters. However, our Chief Financial Officer has served as an executive officer for over ten years, including over five years as an executive officer of public companies. Due to our small size, our board of directors has not designated any Board committee or any other subset of Board members to provide oversight of our cybersecurity program as part of a periodic review of our overall risk management program.</span></p> One of the key responsibilities of our board of directors is informed oversight of our risk management process, including risks from cybersecurity threats. Our board of directors is responsible for monitoring and assessing strategic risk exposure, and our executive officers are responsible for the day-to-day management of the material risks we face and are responsible for reporting to our board of directors any cybersecurity incidents. At present, our three executive officers have no particular experience or training in cybersecurity matters. However, our Chief Financial Officer has served as an executive officer for over ten years, including over five years as an executive officer of public companies. Due to our small size, our board of directors has not designated any Board committee or any other subset of Board members to provide oversight of our cybersecurity program as part of a periodic review of our overall risk management program. 206 MaloneBailey, LLP Houston, Texas 794836 986427 2983841 1805980 2137912 1787308 535938 0 748044 76815 6664633 4656530 140540 0 6805173 4656530 689216 5316 78934 55784 140540 0 2603223 0 3511913 61100 383538 0 3895451 61100 0.001 0.001 100000000 100000000 34124873 34124873 33236091 33236091 34125 33236 28652731 25304732 -25777134 -20742538 2909722 4595430 6805173 4656530 8426835 2645072 6920130 2134725 1506705 510347 6065590 2828147 157305 19154 6222895 2847301 -4716190 -2336954 2011 33644 320417 -0 -318406 33644 -5034596 -2303310 33589818 33589818 33213306 33213306 -0.15 -0.15 -0.07 -0.07 33155127 33155 24872446 -18439228 6466373 80964 81 432286 432367 -2303310 -2303310 33236091 33236 25304732 -20742538 4595430 289870 290 2101198 2101488 55412 55 160345 160400 543500 544 1086456 1087000 -5034596 -5034596 34124873 34125 28652731 -25777134 2909722 -5034596 -2303310 2101488 432367 80570 0 -4253 540000 -90000 90000 1630876 519595 -131864 -703263 606429 -19304 683900 5316 23150 16293 -80570 0 -4425752 -1016362 1087000 0 500000 0 116462 -0 5106343 0 2503120 -0 160400 0 4234161 0 -191591 -1016362 986427 2002789 794836 986427 136580 0 0 0 221110 0 <p id="xdx_80C_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_zYIRRpCSLZLl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>(1) <span id="xdx_826_zoxcvUBYMKVd">Business and Summary of Significant Accounting Policies</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84B_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_z5rf6CO7HYSj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_864_z3HTe1SKqcii">Description of Business</span></i> – NeoVolta Inc. (“we”, “our” or the "Company") is a Nevada corporation, which was formed on March 5, 2018. The Company is a designer, seller and manufacturer of Energy Storage Systems (ESS) which can store and use energy via batteries and an inverter at residential sites. The Company sells its proprietary ESS units through wholesale customers, initially in California, and in an expanding number of other states. In August 2022, the Company completed an underwritten public offering of its equity securities resulting in its common stock and warrants becoming listed on a national exchange (see Note 3).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84D_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zni9PSVsofIb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_862_zvxllrasGC3">Basis of Presentation</span></i> – The accompanying financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and in accordance with the rules and regulations of the United States Securities and Exchange Commission (the “SEC”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_849_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zsV2tdoKaE7l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86D_zsALLhA1GJM">Cash and Cash Equivalents</span></i> – The Company considers all highly liquid accounts with original maturities of three months or less at the date of acquisition to be cash equivalents.  Periodically, the Company may carry cash balances at financial institutions in excess of the federally insured limit of $250,000. As of June 30, 2025, the Company maintained all of its accounts at one bank and the combined balances of all accounts at this bank were in excess of the FDIC insurance limit by $<span id="xdx_90C_eus-gaap--CashUninsuredAmount_iI_pp0p0_c20250630_zReAdSSvMqyb" title="Cash uninsured amount">544,836</span><span style="font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84C_eus-gaap--InventoryPolicyTextBlock_zs8ViRpzReQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_86E_zsdULB4TKD2k"><i>Inventory</i></span> – Inventory consists of batteries and inverters purchased from Asian suppliers and delivered to a location near the Company’s offices, for assembly into ESS units. Inventory is stated at the lower of cost or net realizable value, cost being determined using the first-in, first out (FIFO) method. The Company periodically reviews the value of items in inventory and records an allowance to reduce the carrying value of inventory to the lower of cost or net realizable value based on its assessment of market conditions, inventory turnover and current stock levels. Inventory write-downs are charged to cost of goods sold. The following table presents the components of inventory (net of reserve for obsolescence on assembly parts of zero and $90,000, respectively) as of June 30, 2025 and 2024:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z81k8CkGD46b" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Business and Summary of Significant Accounting Policies (Details - Inventory)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8BB_zdAKnggV2SM4" style="display: none"> Schedule of inventory</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20250630_zpgzNg9puMZi" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_495_20240630_zHEZkoDO7peb" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left"><b> </b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>June 30,</b></td><td style="padding-bottom: 1pt"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left"><b> </b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>2025</b></td><td style="padding-bottom: 1pt"><b> </b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>2024</b></td><td style="padding-bottom: 1pt"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr id="xdx_406_eus-gaap--InventoryRawMaterials_iI_maINzSmu_zTdLuF8Mvkv" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 10pt; width: 66%; text-align: left">Raw materials, consisting of assembly parts, batteries and inverters</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,014,252</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,076,479</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--InventoryWorkInProcess_iI_d0_maINzSmu_ziRzagRKqyd1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Work in process</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">89,386</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--InventoryFinishedGoods_iI_maINzSmu_zLnFyvn4Fy8b" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">123,660</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">621,443</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--InventoryNet_iTI_mtINzSmu_znI8Hut1Ah18" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,137,912</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,787,308</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zTdrwPHm0tLj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p id="xdx_848_eus-gaap--RevenueRecognitionPolicyTextBlock_zYpg5Aa0KEU8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86E_zXRaObgRO2ge">Revenue Recognition</span></i> – The Company recognizes revenue in accordance with Accounting Standard Update ("ASU") 2014-09, Revenue from Contracts with Customers (Topic 606). Revenues are recognized when control of the promised goods is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Identification of the contract with a customer</span></td></tr> <tr style="vertical-align: top"> <td></td><td><span style="font-family: Symbol">·</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Identification of the performance obligations in the contract</span></td></tr> <tr style="vertical-align: top"> <td></td><td><span style="font-family: Symbol">·</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Determination of the transaction price</span></td></tr> <tr style="vertical-align: top"> <td></td><td><span style="font-family: Symbol">·</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Allocation of the transaction price to the performance obligations in the contract</span></td></tr> <tr style="vertical-align: top"> <td></td><td><span style="font-family: Symbol">·</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Recognition of revenue when, or as, the Company satisfies a performance obligation</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company generates revenues from contracts with customers, consisting of a relatively small number of wholesale dealers and installers, in California and several other states. In the year ended June 30, 2025, two such dealers represented approximately <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--DealerOneMember_z7x0pLOraWq2" title="Concentration risk percentage">41</span>% and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--DealerTwoMember_zjtq9UCgUXh9" title="Concentration risk percentage">23</span>% of the Company’s revenues, however, no other dealers accounted for more than 10% of the revenues in such period. Those same two dealers plus one other one represented approximately <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--DealerOneMember_zOIz9huds4eb" title="Concentration risk percentage">39</span>%, <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--DealerTwoMember_zOVA12rPHiKk" title="Concentration risk percentage">12</span>% and <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--DealerThreeMember_zGwMehvn5TC" title="Concentration risk percentage">12</span>% of the Company’s net accounts receivable as of June 30, 2025, however, no other dealers accounted for more than 10% of the accounts receivable as of June 30, 2025. In the year ended June 30, 2024, two such dealers represented approximately <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--DealerOneMember_zlkdbaHvmQM3" title="Concentration risk percentage">20</span>% and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--DealerTwoMember_zuBnfF3ASPh3" title="Concentration risk percentage">14</span>% of the Company’s revenues. Under its present contracts with customers, the Company’s sole performance obligation is the delivery of products to the customer. Since all of the Company’s revenue is currently generated from the sales of similar products delivered to customers in domestic locations, no further disaggregation of revenue information for the years ended June 30, 2025 and 2024 is provided.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_844_eus-gaap--AllowanceForCreditLossesTextBlock_zvjtigBTDlT7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_862_zTUSDCZoKDA4">Allowance for Expected Credit Losses</span> </i>– The Company recognizes an allowance for expected credit losses whenever a loss is expected to be incurred in the realization of a customer’s account. As of June 30, 2025 and 2024, our allowance for expected credit losses was $<span id="xdx_905_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20250630_zavKEF3L7FJj" title="Allowance for credit losses">314,200</span> and $<span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20240630_zE4y30s977H4" title="Allowance for credit losses">1,030,000</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_844_eus-gaap--IncomeTaxPolicyTextBlock_zkc8sh8QMih7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_869_z6s4c6xQ8e87">Income Taxes</span></i> – The Company uses the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and the tax bases of reported assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company must then assess the likelihood that the resulting deferred tax assets will be realized. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts for uncertain tax positions in accordance with the provisions of Accounting Standards Codification (“ASC”) 740-10 which prescribes a recognition threshold and measurement attribute for financial statement disclosure of tax positions taken, or expected to be taken, on its tax return. The Company evaluates and records any uncertain tax positions based on the amount that management deems is more likely than not to be sustained upon examination and ultimate settlement with the tax authorities in the tax jurisdictions in which it operates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84C_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zsDyLbHqjBXl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_867_zrn62TffdGXa">Stock Compensation Expense</span></i> – Employee and non-employee share-based payment compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the requisite service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i> </i></p> <p id="xdx_841_eus-gaap--EarningsPerSharePolicyTextBlock_zUUJU2Lsylo1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86E_zWfvzGtjoIl5">Loss Per Common Share</span></i> – Basic loss per common share is computed by dividing net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of June 30, 2025, the Company had total outstanding common stock equivalents of <span id="xdx_90F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20250630_zTMcT5FGabmf" title="Antidilutive shares">2,937,512</span> shares as follows: (i) <span id="xdx_905_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockUnitsMember_z8pgNfbo9ED7" title="Antidilutive shares">1,806,362</span> shares related to restricted stock units granted to an officer and another employee in April 2024; (ii) <span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--InvestorWarrantsMember_zdd38PZMRUyl" title="Antidilutive shares">1,081,150</span> shares related to warrants issued to investors in the public offering completed in August 2022; and (iii) <span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockUnitsForAnOfficerMember_zNbLDNE2lPqk" title="Antidilutive shares">50,000</span> shares related to restricted stock units granted to an officer in March 2022 (see Note 3).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_843_eus-gaap--ResearchAndDevelopmentExpensePolicy_zIXJtUWhg5xd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_865_zoF9getxdBdb">Research and Development Costs</span></i> – Research and development costs are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84B_eus-gaap--UseOfEstimates_ziiT05qQOwch" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86B_zUVtJHechVPk">Use of Estimates</span></i> – Management has made a number of estimates and assumptions in preparing these financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zyaZpZFhDcSl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_867_z95fG0UVesMk">Segment Information</span></i> – Management has determined that the Company operates in one reportable segment, which is the development and commercialization of energy storage products. The Company's chief operating decision maker (CODM) is its Chief Executive Officer, who reviews financial information presented on a company-wide basis. The CODM primarily uses net loss, which is reported in the Statements of Operations, to assess financial performance and allocate resources. These financial metrics are used by the CODM to make key operating decisions, such as the assessment of segment performance and allocation of resources. The significant categories within net loss that the CODM regularly reviews are revenues from customers, cost of goods sold, and general and administrative expenses. Other expenses reported in the Company’s net loss include interest expense and research and development expenses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i> </i></p> <p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zfJHL6OS1tq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_864_zwvjloxI3hLf">Recent Accounting Pronouncements</span></i> – From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, (“FASB”), or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards, including ASU 2023-07, <i>Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, </i>and prospective standards that are not yet effective, including ASU 2024-03, <i>Income Statement – Reporting Comprehensive Income – Expense disaggregation disclosures (Topic 220-40): Disaggregation of Income Statement Expenses,</i> will not have a material impact on the Company’s financial position or results of operations upon adoption. The Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84D_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zobKkwj4uS32" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_860_zE0fwRz0Rwx">Liquidity</span></i> – These financial statements have been prepared on a going concern basis, which assumes the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The continuation of the Company as a going concern has been dependent upon our ability to obtain the necessary debt and equity financing to continue operations and the attainment of profitable operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As disclosed in Note 2, we entered into an agreement with a financing entity in September 2024 whereby we have obtained a line of credit for borrowings of up to $<span id="xdx_90E_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20240903_zczXtHTmXmk4" title="Line of credit maximum borrowing capacity">5,000,000</span>, in order to meet any near-term borrowing needs. As a result, we believe that we will have sufficient financial resources available to us in order to operate our business for at least the next 12 months from the date these financial statements are issued.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84B_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_z5rf6CO7HYSj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_864_z3HTe1SKqcii">Description of Business</span></i> – NeoVolta Inc. (“we”, “our” or the "Company") is a Nevada corporation, which was formed on March 5, 2018. The Company is a designer, seller and manufacturer of Energy Storage Systems (ESS) which can store and use energy via batteries and an inverter at residential sites. The Company sells its proprietary ESS units through wholesale customers, initially in California, and in an expanding number of other states. In August 2022, the Company completed an underwritten public offering of its equity securities resulting in its common stock and warrants becoming listed on a national exchange (see Note 3).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84D_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zni9PSVsofIb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_862_zvxllrasGC3">Basis of Presentation</span></i> – The accompanying financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and in accordance with the rules and regulations of the United States Securities and Exchange Commission (the “SEC”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_849_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zsV2tdoKaE7l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86D_zsALLhA1GJM">Cash and Cash Equivalents</span></i> – The Company considers all highly liquid accounts with original maturities of three months or less at the date of acquisition to be cash equivalents.  Periodically, the Company may carry cash balances at financial institutions in excess of the federally insured limit of $250,000. As of June 30, 2025, the Company maintained all of its accounts at one bank and the combined balances of all accounts at this bank were in excess of the FDIC insurance limit by $<span id="xdx_90C_eus-gaap--CashUninsuredAmount_iI_pp0p0_c20250630_zReAdSSvMqyb" title="Cash uninsured amount">544,836</span><span style="font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> 544836 <p id="xdx_84C_eus-gaap--InventoryPolicyTextBlock_zs8ViRpzReQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_86E_zsdULB4TKD2k"><i>Inventory</i></span> – Inventory consists of batteries and inverters purchased from Asian suppliers and delivered to a location near the Company’s offices, for assembly into ESS units. Inventory is stated at the lower of cost or net realizable value, cost being determined using the first-in, first out (FIFO) method. The Company periodically reviews the value of items in inventory and records an allowance to reduce the carrying value of inventory to the lower of cost or net realizable value based on its assessment of market conditions, inventory turnover and current stock levels. Inventory write-downs are charged to cost of goods sold. The following table presents the components of inventory (net of reserve for obsolescence on assembly parts of zero and $90,000, respectively) as of June 30, 2025 and 2024:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z81k8CkGD46b" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Business and Summary of Significant Accounting Policies (Details - Inventory)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8BB_zdAKnggV2SM4" style="display: none"> Schedule of inventory</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20250630_zpgzNg9puMZi" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_495_20240630_zHEZkoDO7peb" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left"><b> </b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>June 30,</b></td><td style="padding-bottom: 1pt"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left"><b> </b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>2025</b></td><td style="padding-bottom: 1pt"><b> </b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>2024</b></td><td style="padding-bottom: 1pt"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr id="xdx_406_eus-gaap--InventoryRawMaterials_iI_maINzSmu_zTdLuF8Mvkv" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 10pt; width: 66%; text-align: left">Raw materials, consisting of assembly parts, batteries and inverters</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,014,252</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,076,479</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--InventoryWorkInProcess_iI_d0_maINzSmu_ziRzagRKqyd1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Work in process</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">89,386</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--InventoryFinishedGoods_iI_maINzSmu_zLnFyvn4Fy8b" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">123,660</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">621,443</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--InventoryNet_iTI_mtINzSmu_znI8Hut1Ah18" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,137,912</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,787,308</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zTdrwPHm0tLj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z81k8CkGD46b" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Business and Summary of Significant Accounting Policies (Details - Inventory)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8BB_zdAKnggV2SM4" style="display: none"> Schedule of inventory</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20250630_zpgzNg9puMZi" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_495_20240630_zHEZkoDO7peb" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left"><b> </b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>June 30,</b></td><td style="padding-bottom: 1pt"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left"><b> </b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>2025</b></td><td style="padding-bottom: 1pt"><b> </b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><b>2024</b></td><td style="padding-bottom: 1pt"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr id="xdx_406_eus-gaap--InventoryRawMaterials_iI_maINzSmu_zTdLuF8Mvkv" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 10pt; width: 66%; text-align: left">Raw materials, consisting of assembly parts, batteries and inverters</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,014,252</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,076,479</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--InventoryWorkInProcess_iI_d0_maINzSmu_ziRzagRKqyd1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Work in process</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">89,386</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--InventoryFinishedGoods_iI_maINzSmu_zLnFyvn4Fy8b" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">123,660</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">621,443</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--InventoryNet_iTI_mtINzSmu_znI8Hut1Ah18" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,137,912</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,787,308</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2014252 1076479 0 89386 123660 621443 2137912 1787308 <p id="xdx_848_eus-gaap--RevenueRecognitionPolicyTextBlock_zYpg5Aa0KEU8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86E_zXRaObgRO2ge">Revenue Recognition</span></i> – The Company recognizes revenue in accordance with Accounting Standard Update ("ASU") 2014-09, Revenue from Contracts with Customers (Topic 606). Revenues are recognized when control of the promised goods is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Identification of the contract with a customer</span></td></tr> <tr style="vertical-align: top"> <td></td><td><span style="font-family: Symbol">·</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Identification of the performance obligations in the contract</span></td></tr> <tr style="vertical-align: top"> <td></td><td><span style="font-family: Symbol">·</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Determination of the transaction price</span></td></tr> <tr style="vertical-align: top"> <td></td><td><span style="font-family: Symbol">·</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Allocation of the transaction price to the performance obligations in the contract</span></td></tr> <tr style="vertical-align: top"> <td></td><td><span style="font-family: Symbol">·</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Recognition of revenue when, or as, the Company satisfies a performance obligation</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company generates revenues from contracts with customers, consisting of a relatively small number of wholesale dealers and installers, in California and several other states. In the year ended June 30, 2025, two such dealers represented approximately <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--DealerOneMember_z7x0pLOraWq2" title="Concentration risk percentage">41</span>% and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--DealerTwoMember_zjtq9UCgUXh9" title="Concentration risk percentage">23</span>% of the Company’s revenues, however, no other dealers accounted for more than 10% of the revenues in such period. Those same two dealers plus one other one represented approximately <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--DealerOneMember_zOIz9huds4eb" title="Concentration risk percentage">39</span>%, <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--DealerTwoMember_zOVA12rPHiKk" title="Concentration risk percentage">12</span>% and <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--DealerThreeMember_zGwMehvn5TC" title="Concentration risk percentage">12</span>% of the Company’s net accounts receivable as of June 30, 2025, however, no other dealers accounted for more than 10% of the accounts receivable as of June 30, 2025. In the year ended June 30, 2024, two such dealers represented approximately <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--DealerOneMember_zlkdbaHvmQM3" title="Concentration risk percentage">20</span>% and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--DealerTwoMember_zuBnfF3ASPh3" title="Concentration risk percentage">14</span>% of the Company’s revenues. Under its present contracts with customers, the Company’s sole performance obligation is the delivery of products to the customer. Since all of the Company’s revenue is currently generated from the sales of similar products delivered to customers in domestic locations, no further disaggregation of revenue information for the years ended June 30, 2025 and 2024 is provided.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0.41 0.23 0.39 0.12 0.12 0.20 0.14 <p id="xdx_844_eus-gaap--AllowanceForCreditLossesTextBlock_zvjtigBTDlT7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_862_zTUSDCZoKDA4">Allowance for Expected Credit Losses</span> </i>– The Company recognizes an allowance for expected credit losses whenever a loss is expected to be incurred in the realization of a customer’s account. As of June 30, 2025 and 2024, our allowance for expected credit losses was $<span id="xdx_905_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20250630_zavKEF3L7FJj" title="Allowance for credit losses">314,200</span> and $<span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20240630_zE4y30s977H4" title="Allowance for credit losses">1,030,000</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> 314200 1030000 <p id="xdx_844_eus-gaap--IncomeTaxPolicyTextBlock_zkc8sh8QMih7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_869_z6s4c6xQ8e87">Income Taxes</span></i> – The Company uses the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and the tax bases of reported assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company must then assess the likelihood that the resulting deferred tax assets will be realized. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts for uncertain tax positions in accordance with the provisions of Accounting Standards Codification (“ASC”) 740-10 which prescribes a recognition threshold and measurement attribute for financial statement disclosure of tax positions taken, or expected to be taken, on its tax return. The Company evaluates and records any uncertain tax positions based on the amount that management deems is more likely than not to be sustained upon examination and ultimate settlement with the tax authorities in the tax jurisdictions in which it operates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84C_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zsDyLbHqjBXl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_867_zrn62TffdGXa">Stock Compensation Expense</span></i> – Employee and non-employee share-based payment compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the requisite service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i> </i></p> <p id="xdx_841_eus-gaap--EarningsPerSharePolicyTextBlock_zUUJU2Lsylo1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86E_zWfvzGtjoIl5">Loss Per Common Share</span></i> – Basic loss per common share is computed by dividing net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of June 30, 2025, the Company had total outstanding common stock equivalents of <span id="xdx_90F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20250630_zTMcT5FGabmf" title="Antidilutive shares">2,937,512</span> shares as follows: (i) <span id="xdx_905_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockUnitsMember_z8pgNfbo9ED7" title="Antidilutive shares">1,806,362</span> shares related to restricted stock units granted to an officer and another employee in April 2024; (ii) <span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--InvestorWarrantsMember_zdd38PZMRUyl" title="Antidilutive shares">1,081,150</span> shares related to warrants issued to investors in the public offering completed in August 2022; and (iii) <span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240701__20250630__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockUnitsForAnOfficerMember_zNbLDNE2lPqk" title="Antidilutive shares">50,000</span> shares related to restricted stock units granted to an officer in March 2022 (see Note 3).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> 2937512 1806362 1081150 50000 <p id="xdx_843_eus-gaap--ResearchAndDevelopmentExpensePolicy_zIXJtUWhg5xd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_865_zoF9getxdBdb">Research and Development Costs</span></i> – Research and development costs are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84B_eus-gaap--UseOfEstimates_ziiT05qQOwch" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86B_zUVtJHechVPk">Use of Estimates</span></i> – Management has made a number of estimates and assumptions in preparing these financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zyaZpZFhDcSl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_867_z95fG0UVesMk">Segment Information</span></i> – Management has determined that the Company operates in one reportable segment, which is the development and commercialization of energy storage products. The Company's chief operating decision maker (CODM) is its Chief Executive Officer, who reviews financial information presented on a company-wide basis. The CODM primarily uses net loss, which is reported in the Statements of Operations, to assess financial performance and allocate resources. These financial metrics are used by the CODM to make key operating decisions, such as the assessment of segment performance and allocation of resources. The significant categories within net loss that the CODM regularly reviews are revenues from customers, cost of goods sold, and general and administrative expenses. Other expenses reported in the Company’s net loss include interest expense and research and development expenses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i> </i></p> <p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zfJHL6OS1tq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_864_zwvjloxI3hLf">Recent Accounting Pronouncements</span></i> – From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, (“FASB”), or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards, including ASU 2023-07, <i>Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, </i>and prospective standards that are not yet effective, including ASU 2024-03, <i>Income Statement – Reporting Comprehensive Income – Expense disaggregation disclosures (Topic 220-40): Disaggregation of Income Statement Expenses,</i> will not have a material impact on the Company’s financial position or results of operations upon adoption. The Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84D_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zobKkwj4uS32" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_860_zE0fwRz0Rwx">Liquidity</span></i> – These financial statements have been prepared on a going concern basis, which assumes the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The continuation of the Company as a going concern has been dependent upon our ability to obtain the necessary debt and equity financing to continue operations and the attainment of profitable operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As disclosed in Note 2, we entered into an agreement with a financing entity in September 2024 whereby we have obtained a line of credit for borrowings of up to $<span id="xdx_90E_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20240903_zczXtHTmXmk4" title="Line of credit maximum borrowing capacity">5,000,000</span>, in order to meet any near-term borrowing needs. As a result, we believe that we will have sufficient financial resources available to us in order to operate our business for at least the next 12 months from the date these financial statements are issued.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> 5000000 <p id="xdx_804_eus-gaap--DebtDisclosureTextBlock_zMjmZyRWwlbk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="text-align: left; width: 0.5in"><b>(2)</b></td> <td style="text-align: left"><b><span id="xdx_82D_z5PHCtXWOjml">Debt</span> </b></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 3, 2024, we entered into an agreement with a newly formed financing entity whereby we obtained a line of credit for borrowings of up to $<span id="xdx_906_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20240903_zurG4gHey1H8" title="Line of credit maximum borrowing capacity">5,000,000</span>. Under this agreement, we are obligated to make periodic payments to the lender of accrued interest, at the rate of <span id="xdx_907_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_dp_c20240901__20240903_zTI21uXzBZ7j" title="Line of credit interest rate">16</span>% per annum, on any outstanding borrowings that we make, with the principal and any unpaid accrued interest being due at maturity, which was subsequently extended to <span id="xdx_90C_eus-gaap--DebtInstrumentMaturityDate_dd_c20240901__20240903_zIyyWlHKRfl1" title="Line of credit maturity date">September 3, 2028</span> (see Note 6). In order to secure such borrowings, we have granted a security interest in all of our assets to the lender. As a condition of receiving this line of credit from the lender, we have agreed not to issue any securities pursuant to the Company’s Form S-3 (file number 333-280400), without the lender’s consent, so long as any borrowings remain outstanding. As of June 30, 2025, we had made net borrowings under this credit agreement in the amount of $<span id="xdx_906_eus-gaap--LineOfCreditFacilityCurrentBorrowingCapacity_iI_c20250630_zU4GywusBMc4" title="Net borrowings under this credit agreement">383,538</span>, leaving an available balance of $<span id="xdx_90B_eus-gaap--LineOfCreditFacilityRemainingBorrowingCapacity_iI_c20250630_zzfcF9cHSOv5" title="Line of credit remaining borrowing capacity">4,616,462</span>. Accrued interest as of June 30, 2025 was $<span id="xdx_903_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250630_zpxYHJQLLqMk" title="Accrued interest">30,767</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On October 4, 2024, we made an initial borrowing of $<span id="xdx_900_eus-gaap--ProceedsFromLinesOfCredit_c20241003__20241004__us-gaap--TransactionTypeAxis__custom--CommercialLenderMember_zH5o6s5FSe0a" title="Proceeds from line of credit">250,000</span> under this line of credit largely in order to fund a short-term loan in the same amount to a new customer which has a government-backed contract to install a large number of our units in Puerto Rico over a two year period. The purpose of the loan was to provide working capital to the customer in conjunction with the startup of the contract in Puerto Rico. The loan was structured to be non-interest bearing, if repaid prior to December 31, 2024. The loan was fully repaid in December 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the month of November 2024, we initiated short-term borrowings from a commercial accounts receivable lender under a loan agreement allowing for borrowings, secured by certain property interests, of up to $<span id="xdx_908_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20241130__us-gaap--TransactionTypeAxis__custom--CommercialLenderMember_zLoPUSqWoMx5" title="Line of credit, maximum borrowing capacity">4,000,000</span>. As of June 30, 2025, we had made borrowings from this lender to finance customer shipments and related costs in the total amount of $<span id="xdx_90A_eus-gaap--ProceedsFromLinesOfCredit_c20240701__20250630__us-gaap--TransactionTypeAxis__custom--CommercialLenderMember_zi0q7Rj3ASK3" title="Proceeds from line of credit">5,106,343</span>. The lender charges a placement fee of 1% on each borrowing and assesses interest at the rate of 2.5% per month on the outstanding borrowings. Borrowings are to be repaid upon the earlier of: (i) 120 days from the borrowing date; or (ii) receipt of payment from the customer. In the event of default, interest is assessed at the default rate of 1% per 7 days. Through June 30, 2025, we had repaid $<span id="xdx_906_eus-gaap--RepaymentsOfLinesOfCredit_c20240701__20250630__us-gaap--TransactionTypeAxis__custom--CommercialLenderMember_zcuD8gaKoQh7" title="Repaid borrowings">2,503,120</span> of such borrowings, including accrued interest and fees, leaving an outstanding balance as of that date, including accrued interest and fees, of $<span id="xdx_903_eus-gaap--LineOfCredit_iI_c20250630__us-gaap--TransactionTypeAxis__custom--CommercialLenderMember_zNDdmr2I4wq7" title="Outstanding balance">2,603,223</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> 5000000 0.16 2028-09-03 383538 4616462 30767 250000 4000000 5106343 2503120 2603223 <p id="xdx_80A_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zDuP1buMN6j4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="text-align: left; width: 0.5in"><b>(3)</b></td> <td style="text-align: left"><b><span id="xdx_82C_zFR0yT040Qs2">Equity</span> </b></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Common Stock</i> – In February 2025, the Company closed a private equity offering under which the Company issued a total of <span id="xdx_90D_eus-gaap--SharesIssued_iI_c20250228__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateEquityOfferingMember_zktXtSkNpBP8" title="Issued shares of common stock">543,500</span> shares of its common stock to the investors at an offering price of $<span id="xdx_902_eus-gaap--SharePrice_iI_c20250228__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateEquityOfferingMember_zQjIvKosSN95" title="Offering price">2.00</span> per share resulting in gross proceeds to the Company in the amount of $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20250201__20250228__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivateEquityOfferingMember_zuAp6d2ySEpc" title="Gross proceeds">1,087,000</span>. The Company is using the proceeds of this private offering to meet working capital needs and for other general corporate purposes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In August 2022, the Company completed an underwritten public offering of its equity securities in the form of Units with <span id="xdx_90A_ecustom--UnitDescription_c20220801__20220831__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember_zGFHfjyLrhD3" title="Unit descriptioon">each Unit consisting of one share of common stock and one warrant</span> (each, a “Warrant” and collectively, the “Warrants”) to purchase one share of common stock at an exercise price of $4.00 per share. The shares of common stock and the Warrants comprising the Units were immediately separated at closing of the offering and each is now independently listed on the NASDAQ Capital Market. Each Warrant became exercisable on the date of issuance and will expire five years from the date of issuance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the underwritten public offering, a total of <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220801__20220831__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember__us-gaap--StatementClassOfStockAxis__custom--UnitsMember_zzKqggMInq4b" title="Stock issued new, shares">1,121,250</span> Units, including exercise of the underwriter’s overallotment option, were sold at an offering price to the public of $4.00 per Unit. The gross proceeds of the offering were $<span id="xdx_907_ecustom--GrossProceedsFromIssuanceOrSaleOfEquity_c20220801__20220831__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember__us-gaap--StatementClassOfStockAxis__custom--UnitsMember_zHytFsN9Bk43" title="Gross proceeds from sale of equity">4,485,000</span> and the net proceeds, after deduction of underwriting discounts and other offering costs were approximately $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20220801__20220831__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember__us-gaap--StatementClassOfStockAxis__custom--UnitsMember_zTTUppPlafi7" title="Proceeds from sale of equity">3,780,000</span>. The Company also granted the underwriter non-tradeable warrants to purchase a total of <span id="xdx_908_ecustom--WarrantsIssuedShares_c20220801__20220831__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember__srt--CounterpartyNameAxis__custom--UnderwriterMember_zDdjeK8Ir9Tc" title="Warrants issued, shares">58,500</span> shares of common stock at an exercise price of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220831__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember__srt--CounterpartyNameAxis__custom--UnderwriterMember_z8I4ZTwCe4f1" title="Warrants issued, exercise price">4.40</span> per share for a period of five years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In conjunction with the public offering, all holders of the Company’s 2018 convertible notes in the total amount of $<span id="xdx_909_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20220801__20220831__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotes2018Member_zDjgwKvz05ij" title="Debt converted, amount converted">59,251</span>, including accrued interest, converted their debt into a total of <span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20220801__20220831__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotes2018Member_ze1EPJ5huXbd" title="Debt converted, shares issued">9,404,867</span> shares of common stock at the stated conversion rate, and all holders of the Company’s 2021 convertible notes in the total amount of $<span id="xdx_90C_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20220801__20220831__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotes2021Member_z3Jgpl0prXib" title="Debt converted, amount converted">1,068,000</span> converted their debt into a total of <span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20220801__20220831__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwrittenPublicOfferingMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotes2021Member_zAADimCE1bl" title="Debt converted, shares issued">267,000</span> shares of common stock at the stated conversion rate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Warrants</i> – The Warrants for a total of <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250630_ziseAGAw7bM2" title="Warrants outstanding">1,179,750</span> shares of common stock issued to investors and the underwriters are exercisable at any time after their original issuance and at any time up to the date that is five years after their original issuance, or <span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630_zQF21F1MmFph" title="Warrants maturity date">August 1, 2027</span>. The Warrants may be exercised upon payment of the exercise price in cash on or prior to the expiration date. Under the terms of the Warrant Agreement, we must use our best efforts to maintain the effectiveness of the registration statement and current prospectus relating to common stock issuable upon exercise of the Warrants until the expiration of the Warrants. If we fail to maintain the effectiveness of the registration statement and current prospectus relating to the common stock issuable upon exercise of the Warrants, the holders of the Warrants shall have the right to exercise the Warrants solely via a cashless exercise feature provided for in the Warrants, until such time as there is an effective registration statement and current prospectus. In June 2024, the Company filed an updated registration statement applicable to the exercise of the Warrants.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table presents activity with respect to the Company’s warrants for the years ended June 30, 2025 and 2024:</p> <table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zhbanIqiopsc" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto" summary="xdx: Disclosure - Equity (Details - Warrant activity)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B5_zjF1yBcuVG1k" style="display: none">Schedule of warrant activity</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Wtd. Avg.</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Wtd. Avg.</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Aggregate</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">of</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Remaining</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Intrinsic</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Price</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Term (Yrs.)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 40%">Outstanding at July 1, 2023</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_d0_c20230701__20240630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zsbR0tktSELa" style="width: 12%; text-align: right" title="Warrants outstanding, beginning">1,179,750</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_d0_c20230701__20240630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zjwgJskX3Q5j" style="width: 12%; text-align: right" title="Warrants outstanding, weighted average exercise price, beginning">4.02</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYp_c20230630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zgQodSnfWCh9" style="width: 12%; text-align: right" title="Warrants outstanding, term">4.1</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iI_d0_c20230630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zWgMLr21ihje" style="width: 12%; text-align: right" title="Warrants outstanding, aggregate intrinsic value">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrants issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20230701__20240630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zqkhUAgKwyK7" style="text-align: right" title="Warrants issued">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d0_c20230701__20240630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zt5HP9l0PiS" style="text-align: right" title="Warrants issued, weighted average exercise price">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Warrants exercised/forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di0_c20230701__20240630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zenVGUex2U69" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants exercised/forfeited">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_iN_di0_c20230701__20240630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zGSqoKJQqcJ" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants exercised/forfeited, weighted average exercise price">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Outstanding at June 30, 2024</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_d0_c20240701__20250630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zzI4liaJYN16" style="text-align: right" title="Warrants outstanding, beginning">1,179,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_d0_c20240701__20250630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zyJw28Q9rrl8" style="text-align: right" title="Warrants outstanding, weighted average exercise price, beginning">4.02</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYp_c20240630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zT23e19esTdj" style="text-align: right" title="Warrants outstanding, term">3.1</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iI_d0_c20240630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zrJqAEjaXT21" style="text-align: right" title="Warrants outstanding, aggregate intrinsic value">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Warrants issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20240701__20250630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zmHz1eyJrsX7" style="text-align: right" title="Warrants issued">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d0_c20240701__20250630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zCot0Kij6dM4" style="text-align: right" title="Warrants issued, weighted average exercise price">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Warrants exercised/forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di0_c20240701__20250630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zfVwVNNM7Kk3" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants exercised/forfeited">(98,600</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_iN_di0_c20240701__20250630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zgI4OVaRzdh8" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants exercised/forfeited, weighted average exercise price">(4.24</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Outstanding at June 30, 2025</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_d0_c20240701__20250630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zWhe7DN36C0h" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, ending">1,081,150</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_d0_c20240701__20250630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zBvARi2OU4yl" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, weighted average exercise price, ending">4.00</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYp_c20250630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zipxPcYsK2t7" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, term">2.1</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iI_d0_c20250630__us-gaap--AwardTypeAxis__custom--WarrantsMember_z3kz9zNP3Usj" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, aggregate intrinsic value">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Exercisable at June 30, 2025</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightExercisable_iI_d0_c20250630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zcL8fodBM4Ch" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants exercisable">1,081,150</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice_iI_d0_c20250630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zr41pKWGRr6h" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants exercisable, weighted average exercise price">4.00</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_ecustom--WarrantsAndRightsOutstandingTermExercisable_iI_dtYp_c20240701__20250630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zJ2J2MDOLZ01" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants exercisable, term">2.1</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable_iI_d0_c20250630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zyPsFwDdH3T6" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants exercisable, aggregate intrinsic value">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These warrants were issued in conjunction with an underwritten public equity offering, therefore, there was no employee or non-employee compensation expense recognized. In November 2024, the underwriter elected to exercise all <span id="xdx_908_eus-gaap--ConversionOfStockSharesConverted1_c20241101__20241130__us-gaap--AwardTypeAxis__custom--WarrantsMember_zDtA4qv9jF7a" title="Warrants converted, shares">58,500</span> Warrants at an exercise price of $4.40 per share, via a cashless exercise, as permitted under the warrant agreement, resulting in the issuance of <span id="xdx_909_eus-gaap--ConversionOfStockSharesIssued1_c20241101__20241130__us-gaap--AwardTypeAxis__custom--WarrantsMember_ziKruBeoCPXa" title="Warrants converted, shares issued">15,312</span> shares of our common stock. Additionally, the holders of publicly issued Warrants to purchase an aggregate of <span id="xdx_90B_ecustom--WarrantsExercised_c20241101__20241130__us-gaap--AwardTypeAxis__custom--WarrantsMember_zk0lCnXT1P9h" title="Warrants exercised, shares">40,100</span> shares of our common stock elected to exercise their Warrants by a cash payment of a total of $<span id="xdx_904_eus-gaap--ProceedsFromWarrantExercises_c20241101__20241130__us-gaap--AwardTypeAxis__custom--WarrantsMember_znHc7JFQZYNd" title="Cash payments">160,400</span> resulting in the issuance of the underlying shares of our common stock in December 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Stock Compensation Expense</i> – In April 2024, we entered into an employment agreement with a new Chief Executive Officer (“CEO”), providing for an initial term extending through June 30, 2027, which will be automatically renewed for additional one-year terms unless either party chooses not to renew it. Pursuant to the agreement, our new CEO received an initial equity grant equal to <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20240401__20240430__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zfrPV62iD6z7" title="Grants in period, shares">1,280,000</span> restricted stock units (“RSUs”), with a grant date value of $<span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodValue_c20240401__20240430__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zUZ37wXovwA5" title="Grant date fair value">2,854,000</span>, <span style="font-family: Times New Roman, Times, Serif">which will vest over a four-year period, subject to his continued employment with the Company,</span> and will be entitled to earn additional RSUs on each anniversary in the form of <span style="font-family: Times New Roman, Times, Serif">three annual performance-based equity grants.</span> However, our Compensation Committee has not set any definitive targets, therefore, no additional grants have been made as of June 30, 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In February 2025, we entered into an amended and restated employment agreement with our Chief Financial Officer (“CFO”). The initial term of the employment agreement ends on December 31, 2027 and will be automatically renewable for additional one-year terms unless either party chooses not to renew the agreement. Pursuant to the agreement, we issued our CFO an award of <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20250201__20250228__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zjAVWJvjsEOi" title="Grants in period, shares">240,000</span> RSUs vesting in four annual installments on each anniversary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In February 2022, we entered into a new employment agreement with our CFO pursuant to which we issued him an RSU award for up to <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20220201__20220228__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQQNxdUKE3Vh" title="Grants in period, shares">300,000</span> shares of our common stock upon achieving two defined milestones. The first milestone was achieved as of January 1, 2023, and the underlying <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20221230__20230102__srt--CounterpartyNameAxis__srt--ChiefFinancialOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--TransactionTypeAxis__custom--Milestone1Member_zPIKeYD4oQc1" title="Common stock shares issued">250,000</span> shares of common stock were issued to our CFO as of that date. The second milestone was achieved as of January 1, 2024, and the underlying <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20231230__20240102__srt--CounterpartyNameAxis__srt--ChiefFinancialOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--TransactionTypeAxis__custom--Milestone2Member_zScmAbMG9DE7" title="Common stock shares issued">50,000</span> shares of common stock are expected to be issued to our CFO at a later date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In January 2025, we entered into an employment agreement with our new Chief Operating Officer (“COO”). The initial term of the employment agreement ends on December 31, 2027 and will be automatically renewable for additional one-year terms unless either party chooses not to renew the agreement. Pursuant to the agreement, we issued our COO an award of <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20250101__20250131__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zAzRDO6Ua5z1" title="Grants in period, shares">150,000</span> RSUs vesting in three annual installments. Additionally, we entered into employment agreements with two other individuals in June 2024 and October 2024, and we issued them a total of <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20240601__20240630__srt--TitleOfIndividualAxis__custom--TwoOtherIndividualsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zw54f6kfpi13" title="Grants in period, shares"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20241001__20241031__srt--TitleOfIndividualAxis__custom--TwoOtherIndividualsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zumNIa38k2Di" title="Grants in period, shares">136,362</span></span> RSUs vesting in four annual installments. As a result, we presently have a total of <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20250101__20250131__srt--TitleOfIndividualAxis__custom--ThreeOfficersAndTwoOtherIndividualsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zZfJ1jEWa1" title="Grants in period, shares">1,806,362</span> RSUs that have been issued to our three officers and two other individuals. For all of these awards, we have calculated the grant date value of such awards and are amortizing it as stock compensation expense over the underlying vesting periods. We have recognized stock compensation expense applicable to such RSU awards in the years ended June 30, 2025 and 2024 in the amounts of $<span id="xdx_908_eus-gaap--ShareBasedCompensation_c20240701__20250630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--CounterpartyNameAxis__custom--ThreeOfficersAndTwoOtherIndividualsMember_zUubwVyCwuq2" title="Share based compensation">1,011,405</span> and $<span id="xdx_900_eus-gaap--ShareBasedCompensation_c20230701__20240630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--CounterpartyNameAxis__custom--ThreeOfficersAndTwoOtherIndividualsMember_zYCxacdwufc7" title="Share based compensation">214,992</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In February 2025, we entered into a referral agreement with a marketing company to market our products to qualified solar and energy storage system installers. The term of the referral agreement ends on December 31, 2026. Pursuant to the agreement, the only compensation that the marketing company will be entitled to receive will be through the issuance of shares of our common stock in exchange for reaching specified target levels of product sales, up to a maximum total of 2,000,000 shares for reaching a total of 2,500 units sold and paid for. In accordance with ASC 718, we are accounting for this agreement based on our periodic assessments of the probability of reaching such target levels. Based on that approach, we have recognized stock compensation expense as of June 30, 2025, in the amount of $165,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In conjunction with our public offering in August 2022, we appointed two new independent directors and adopted a new compensation plan for all independent directors based on an annual compensation amount of $65,000 to be paid quarterly with not less than 70% of such amount paid in shares of our common stock, calculated based on the share price at the end of such prior fiscal quarter, and up to 30% paid in cash, with such final amounts to be determined by each director. As of June 30, 2025 and 2024, we booked an annual accrual of $<span id="xdx_903_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_c20250630__srt--CounterpartyNameAxis__custom--TwoDirectorsMember_zy6BsPWr7D0i" title="Accrued compensation">195,000</span> of compensation expense (of which $175,500 will be settled through the issuance of shares) for our three independent directors under this plan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the year ended June 30, 2025, we recognized total non-cash stock compensation expense of $<span id="xdx_903_eus-gaap--ShareBasedCompensation_c20240701__20250630_zw94z4eW4m26" title="Share-based compensation expense">2,101,488</span> as follows: (i) $<span id="xdx_900_eus-gaap--ShareBasedCompensation_c20240701__20250630__us-gaap--TransactionTypeAxis__custom--AmortizedValueOfRSUsMember_zelFv4FIJywc">1,011,405</span> for the amortized value of the RSUs granted to our three officers and two other individuals; (ii) $<span id="xdx_90B_eus-gaap--ShareBasedCompensation_c20240701__20250630__us-gaap--TransactionTypeAxis__custom--NewCompensationPlanMember_zVo6cUpFcfR6">175,500</span> for the amortized value of the portion of the new compensation plan for our independent directors that is attributable to stock; (iii) $<span id="xdx_900_eus-gaap--ShareBasedCompensation_c20240701__20250630__us-gaap--TransactionTypeAxis__custom--IssuanceOfSharesForAdvisoryServicesMember_z4EtDpF2Vwoc">515,498</span> for the fair value of the issuance of <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20240701__20250630__us-gaap--TransactionTypeAxis__custom--IssuanceOfSharesForAdvisoryServicesMember_zLXkpc6Z1hb" title="Stock issued for services, shares">174,650</span> shares of our common stock to two consultants for their advisory services in the area of energy regulatory and marketing matters; (iv) $<span id="xdx_90F_eus-gaap--ShareBasedCompensation_c20240701__20250630__us-gaap--TransactionTypeAxis__custom--AmortizedValueOfCompensationPlanMember_zbr8q2dsomcf">234,085</span> for the grant date value of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20240701__20250630__us-gaap--TransactionTypeAxis__custom--AmortizedValueOfCompensationPlanMember_z6w0VaNZ2jD1">78,565</span> shares of common stock to be issued to a distributor as a sales incentive pursuant to a February 2025 distribution agreement; and (v) $<span id="xdx_903_eus-gaap--ShareBasedCompensation_c20240701__20250630__us-gaap--TransactionTypeAxis__custom--IssuanceOfSharesForConsultingAndMarketingServicesMember_ziAZNjHr0o5c">165,000</span> for the amortized value of the shares potentially issuable to a marketing company pursuant to a February 2025 referral agreement. There was a total of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20240701__20250630__srt--CounterpartyNameAxis__custom--VariousGranteesMember_zY3NT4qGM5Fl">289,870</span> shares of our common stock that were issued to various grantees for services in the year ended June 30, 2025, of which <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20240701__20250630__us-gaap--TransactionTypeAxis__custom--RecognizedInPriorYearMember__srt--CounterpartyNameAxis__custom--VariousGranteesMember_zq10y7segmra">125,620</span> shares were previously expensed in the year ended June 30, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the year ended June 30, 2024, we recognized total non-cash stock compensation expense of $<span id="xdx_905_eus-gaap--ShareBasedCompensation_c20230701__20240630_zPCAsp9rLk12" title="Share-based compensation expense">432,367</span> as follows: (i) $<span id="xdx_906_eus-gaap--ShareBasedCompensation_c20230701__20240630__us-gaap--TransactionTypeAxis__custom--AmortizedValueOfRSUsMember_zNRUgOSAjU07">214,992</span> for the amortized value of the RSUs granted to our three executive officers and a non-executive recipient, as previously described; (ii) $<span id="xdx_904_eus-gaap--ShareBasedCompensation_c20230701__20240630__us-gaap--TransactionTypeAxis__custom--AmortizedValueOfCompensationPlanMember_zvPZgEHLxni5">175,500</span> for the amortized value of the portion of the new compensation plan for our independent directors that is attributable to stock; (iii) $<span id="xdx_908_eus-gaap--ShareBasedCompensation_c20230701__20240630__us-gaap--TransactionTypeAxis__custom--AmortizedValueOfSharesGrantedMember_zIWl6tofFDLj">29,450</span> for the net amortized value of the shares granted to various advisors under their annual service contracts; and (iv) $<span id="xdx_902_eus-gaap--ShareBasedCompensation_c20230701__20240630__us-gaap--TransactionTypeAxis__custom--FairValueOfIncentiveSharesMember_zbqSG1niRL1b">12,425</span> for the fair value of incentive shares earned by a wholesale dealer as of December 31, 2023 (see Note 5). There was a total of <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20230701__20240630__srt--CounterpartyNameAxis__custom--IndependentDirectorsMember_ztPHltQF76h2">80,964</span> shares of common stock that were issued to our independent directors in the year ended June 30, 2024, which were previously expensed in the year ended June 30, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Other Matters</i> – In February 2019, the Company’s Board of Directors approved the establishment of a new 2019 Stock Option Plan with an authorization for the issuance of up to <span id="xdx_900_eus-gaap--DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance_iI_c20190228__us-gaap--PlanNameAxis__custom--StockPlan2019Member_zjoX9i1LsuW7" title="Shares authorized for issuance under plan">2,500,000</span> shares of common stock. In December 2024, the Plan was amended to increase the number of shares of common stock authorized for issuance by <span id="xdx_900_eus-gaap--DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance_iI_c20241231__us-gaap--PlanNameAxis__custom--StockPlan2019Member_z2WHQJsVEj6l" title="Shares authorized for issuance under plan">5,000,000</span> shares. The Plan is designed to provide for future discretionary grants of stock options, stock awards and stock unit awards to key employees and non-employee directors. As of June 30, 2025, we have made total awards of <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240701__20250630__us-gaap--PlanNameAxis__custom--StockPlan2019Member_zJEjf3By9jH4" title="Shares granted">2,615,054</span> shares under the Plan as follows: (i) <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240701__20250630__us-gaap--PlanNameAxis__custom--StockPlan2019Member__srt--CounterpartyNameAxis__custom--ThreeExecutiveOfficersAndNonExecutiveMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zNNPrD7e7YF2" title="Shares granted">2,256,362</span> shares for the RSUs granted to our three executive officers and two non-executive recipients, as noted above; (ii) <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240701__20250630__us-gaap--PlanNameAxis__custom--StockPlan2019Member__srt--CounterpartyNameAxis__custom--ThreeIndependentDirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zad3t3EkTqLl" title="Shares granted">153,808</span> shares for the services of our three independent directors in the years ended June 30, 2024 and 2023, pursuant to the new compensation plan adopted for independent directors in August 2022; and (iii) <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240701__20250630__us-gaap--PlanNameAxis__custom--StockPlan2019Member__srt--CounterpartyNameAxis__custom--SeveralWholesaleDealersMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zKWIFKQF3gSb" title="Shares granted">204,884</span> shares granted to various consultants for their services and to wholesale dealers under an incentive sales program.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> 543500 2.00 1087000 each Unit consisting of one share of common stock and one warrant 1121250 4485000 3780000 58500 4.40 59251 9404867 1068000 267000 1179750 2027-08-01 <table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zhbanIqiopsc" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto" summary="xdx: Disclosure - Equity (Details - Warrant activity)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B5_zjF1yBcuVG1k" style="display: none">Schedule of warrant activity</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Wtd. Avg.</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Wtd. Avg.</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Aggregate</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">of</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Remaining</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Intrinsic</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Price</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Term (Yrs.)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 40%">Outstanding at July 1, 2023</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_d0_c20230701__20240630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zsbR0tktSELa" style="width: 12%; text-align: right" title="Warrants outstanding, beginning">1,179,750</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_d0_c20230701__20240630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zjwgJskX3Q5j" style="width: 12%; text-align: right" title="Warrants outstanding, weighted average exercise price, beginning">4.02</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYp_c20230630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zgQodSnfWCh9" style="width: 12%; text-align: right" title="Warrants outstanding, term">4.1</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iI_d0_c20230630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zWgMLr21ihje" style="width: 12%; text-align: right" title="Warrants outstanding, aggregate intrinsic value">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrants issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20230701__20240630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zqkhUAgKwyK7" style="text-align: right" title="Warrants issued">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d0_c20230701__20240630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zt5HP9l0PiS" style="text-align: right" title="Warrants issued, weighted average exercise price">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Warrants exercised/forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di0_c20230701__20240630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zenVGUex2U69" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants exercised/forfeited">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_iN_di0_c20230701__20240630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zGSqoKJQqcJ" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants exercised/forfeited, weighted average exercise price">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Outstanding at June 30, 2024</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_d0_c20240701__20250630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zzI4liaJYN16" style="text-align: right" title="Warrants outstanding, beginning">1,179,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_d0_c20240701__20250630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zyJw28Q9rrl8" style="text-align: right" title="Warrants outstanding, weighted average exercise price, beginning">4.02</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYp_c20240630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zT23e19esTdj" style="text-align: right" title="Warrants outstanding, term">3.1</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iI_d0_c20240630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zrJqAEjaXT21" style="text-align: right" title="Warrants outstanding, aggregate intrinsic value">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Warrants issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20240701__20250630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zmHz1eyJrsX7" style="text-align: right" title="Warrants issued">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d0_c20240701__20250630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zCot0Kij6dM4" style="text-align: right" title="Warrants issued, weighted average exercise price">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Warrants exercised/forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di0_c20240701__20250630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zfVwVNNM7Kk3" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants exercised/forfeited">(98,600</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_iN_di0_c20240701__20250630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zgI4OVaRzdh8" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants exercised/forfeited, weighted average exercise price">(4.24</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Outstanding at June 30, 2025</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_d0_c20240701__20250630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zWhe7DN36C0h" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, ending">1,081,150</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_d0_c20240701__20250630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zBvARi2OU4yl" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, weighted average exercise price, ending">4.00</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYp_c20250630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zipxPcYsK2t7" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, term">2.1</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iI_d0_c20250630__us-gaap--AwardTypeAxis__custom--WarrantsMember_z3kz9zNP3Usj" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, aggregate intrinsic value">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Exercisable at June 30, 2025</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightExercisable_iI_d0_c20250630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zcL8fodBM4Ch" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants exercisable">1,081,150</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice_iI_d0_c20250630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zr41pKWGRr6h" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants exercisable, weighted average exercise price">4.00</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_ecustom--WarrantsAndRightsOutstandingTermExercisable_iI_dtYp_c20240701__20250630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zJ2J2MDOLZ01" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants exercisable, term">2.1</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable_iI_d0_c20250630__us-gaap--AwardTypeAxis__custom--WarrantsMember_zyPsFwDdH3T6" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants exercisable, aggregate intrinsic value">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1179750 4.02 P4Y1M6D 0 0 0 -0 -0 1179750 4.02 P3Y1M6D 0 0 0 98600 4.24 1081150 4.00 P2Y1M6D 0 1081150 4.00 P2Y1M6D 0 58500 15312 40100 160400 1280000 2854000 240000 300000 250000 50000 150000 136362 136362 1806362 1011405 214992 195000 2101488 1011405 175500 515498 174650 234085 78565 165000 289870 125620 432367 214992 175500 29450 12425 80964 2500000 5000000 2615054 2256362 153808 204884 <p id="xdx_808_eus-gaap--IncomeTaxDisclosureTextBlock_zFtvw8BcUuQf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0"></td><td style="width: 0.5in; text-align: left"><b>(4)</b></td><td style="text-align: justify"><b><span id="xdx_82B_zpvSGtyM02ue">Income Taxes</span></b></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is subject to United States federal income taxes at an approximate rate of 21%. The reconciliation of the provision for income taxes at the federal statutory rate, compared to the Company’s income tax expense as reported, is as follows (rounded to nearest $00):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zXbqPe9SQ2Tc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details - Schedule of income tax expense)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B5_zqRr7dFoyJfi" style="display: none">Schedule of income tax expense</span></td><td> </td> <td colspan="2" id="xdx_49D_20240701__20250630_zDrUhoXJ42s3" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_491_20230701__20240630_zYLQdCqbP7rb" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended June 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_401_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzdg2_zvl1H7XlHSp" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Income tax benefit computed at statutory rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">747,900</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">279,400</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzdg2_zFlk3AU95RW1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Change in valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(747,900</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(279,400</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--IncomeTaxExpenseBenefit_d0_mtITEBzdg2_zfYvo3Q4oAY7" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Provision for income taxes</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Significant components of the Company’s deferred tax assets at the currently enacted corporate income tax rate are as follows (rounded to nearest $00):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zol3oRe9nKZg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details - Schedule of deferred taxes)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B8_z3Lgy3LacN9b" style="display: none">Schedule of deferred taxes</span></td><td> </td> <td colspan="2" id="xdx_493_20250630_zSHe4nSqFBz6" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_492_20240630_zfgf7v6lUrmi" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40F_eus-gaap--DeferredIncomeTaxesAbstract_iB_zdUnsBWdw0sb" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Deferred income tax assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_zj0ss3DWpTkh" style="vertical-align: bottom; background-color: White"> <td style="width: 66%; text-align: left; padding-left: 10pt">Net operating losses</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,570,100</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">824,300</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_zcfAaVgcfnQ6" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,570,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(824,300</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--DeferredTaxAssetsNet_iI_d0_zGpo2wfYI7qf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Net deferred income tax assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has a cumulative tax operating loss carry forward as of June 30, 2025 of approximately $<span id="xdx_90F_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20250630_zw1ZMfGzb976" title="Operating loss carry forward">7,477,000</span>, with an indefinite expiration period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zXbqPe9SQ2Tc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details - Schedule of income tax expense)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B5_zqRr7dFoyJfi" style="display: none">Schedule of income tax expense</span></td><td> </td> <td colspan="2" id="xdx_49D_20240701__20250630_zDrUhoXJ42s3" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_491_20230701__20240630_zYLQdCqbP7rb" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended June 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_401_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzdg2_zvl1H7XlHSp" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Income tax benefit computed at statutory rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">747,900</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">279,400</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzdg2_zFlk3AU95RW1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Change in valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(747,900</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(279,400</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--IncomeTaxExpenseBenefit_d0_mtITEBzdg2_zfYvo3Q4oAY7" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Provision for income taxes</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 747900 279400 -747900 -279400 0 0 <table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zol3oRe9nKZg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details - Schedule of deferred taxes)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B8_z3Lgy3LacN9b" style="display: none">Schedule of deferred taxes</span></td><td> </td> <td colspan="2" id="xdx_493_20250630_zSHe4nSqFBz6" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_492_20240630_zfgf7v6lUrmi" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40F_eus-gaap--DeferredIncomeTaxesAbstract_iB_zdUnsBWdw0sb" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Deferred income tax assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_zj0ss3DWpTkh" style="vertical-align: bottom; background-color: White"> <td style="width: 66%; text-align: left; padding-left: 10pt">Net operating losses</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,570,100</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">824,300</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_zcfAaVgcfnQ6" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,570,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(824,300</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--DeferredTaxAssetsNet_iI_d0_zGpo2wfYI7qf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Net deferred income tax assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1570100 824300 1570000 824300 0 0 7477000 <p id="xdx_80A_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zZedQMBKI6Z7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.5in"><b>(5)</b></td><td style="text-align: justify"><b><span id="xdx_825_zkDT8K0rdE1h">Commitments and Contingencies</span> </b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Effective January 1, 2021, we secured new corporate and manufacturing office space under a sublease agreement with a company that served as our contract manufacturer at that time. Under the terms of the sublease agreement, we were required to make rental payments of $<span id="xdx_905_eus-gaap--PaymentsForRent_c20210101__20241231_zqZ1G1NWtkX1" title="Monthly rental payments">10,350</span> per month during the initial one-year term of the agreement. Further, under the terms of the sublease agreement, we were granted the right to renew the sublease for additional terms of 12 months each upon mutual agreement of both parties, provided thirty days’ notice is given for each subsequent term, at a modest increase in the monthly rent, through December 31, 2024. However, we were under no obligation to renew it. At inception of the sublease, management determined that exercise of the renewal option was not reasonably certain and, notwithstanding that the Company elected to renew the agreement for additional one year periods as of January 1, 2022, 2023 and 2024. Accordingly, we have accounted for it as a short-term lease under ASC 842, <i>Leases</i>. Effective December 31, 2024, the parties mutually agreed to a short-term extension of the sublease agreement, on essentially the same terms, through February 28, 2025. Prior to expiration of the extended sublease, the Company relocated its corporate and manufacturing office space to another facility in the same vicinity under a 13 month sublease agreement with the sublandlord, at a base rental of $<span id="xdx_905_eus-gaap--PaymentsForRent_c20250101__20250228_z0b6Jb0DgHMb" title="Monthly rental payments">18,638</span> per month. We are accounting for the lease agreement as an operating lease under ASU 2016-02, <i>Leases (Topic 842)</i>. Accordingly, the Company has capitalized the present value of the future lease obligations and is amortizing the related right-of-use asset on a straight-line basis each month over the term of the lease.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As indicated in Note 1, the Company sells its proprietary ESS units through wholesale dealers, primarily in California. In that regard, the Company has entered into agreements with several wholesale dealers operating in California and other states under which the Company has incentivized the dealers to achieve quarterly sales above targeted levels by agreeing to grant them shares of the Company’s common stock for exceeding such quarterly sales targets, subject to defined maximums, as determined annually on a calendar year basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are dependent on our two main component vendors for our suppliers of batteries, inverters and other raw materials and the inability of these single-source suppliers to deliver necessary components of our products according to our schedule and at prices, quality levels and volumes acceptable to us, or our inability to efficiently manage these components, could have a material adverse effect on our financial condition and operating results. Beginning in April 2025, the Trump Administration implemented a significant increase in tariff rates on all goods imported from China, although it was temporarily suspended for 90 days in April 2025 and the suspension has recently been extended to early November 2025. Prior to the tariff escalation in April 2025, we had anticipated the likelihood of facing such a tariff increase and began stockpiling our inventory of these two components. As a result, we do not anticipate having to purchase a significant level of such components at post-tariff prices for the next several months.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time in the ordinary course of our business, the Company may be involved in legal proceedings, the outcomes of which may not be determinable. The Company is not involved in any legal proceedings at this time. The results of litigation are inherently unpredictable. Any claims against us, whether meritorious or not, could be time consuming, result in costly litigation, require significant amounts of management time and result in diversion of significant resources. We are not able to estimate an aggregate amount or range of reasonably possible losses for those legal matters for which losses are not probable and estimable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> 10350 18638 <p id="xdx_805_eus-gaap--SubsequentEventsTextBlock_zJpZVdZPBHh4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.5in"><b>(6)</b></td><td><b><span id="xdx_82E_zbhwfGl7rAq3">Subsequent Events</span> </b></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July 4, 2025, Congress passed, and the President signed into law the <i>One Big Beautiful Bill Act (“OBBB”). </i>Among other provisions, it extends many of the expiring provisions from the <i>Tax Cuts and Jobs Act</i> of 2017 and <span style="background-color: white">phases out a number of clean energy tax incentives, including credits for the installation of residential solar panels. Based on our preliminary analysis, however, we do not expect passage of the OBBB to have a material impact on our business. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July 23, 2025, we issued 78,565 shares of common stock to a wholesale distributor as a sales incentive pursuant to a February 2025 distribution agreement and 10,400 shares of common stock to a product marketing consultant pursuant to a February 2025 letter agreement, which were previously expensed in the year ended June 30, 2025 (see Note 3).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 22, 2025, we issued Non-Qualified Stock Options to a group of our employees to purchase a total of 144,000 shares of our common stock at the current stock price of $3.60 per share, pursuant to the provisions of our 2019 Stock Option Plan. These options are exercisable for a period of 5 years from the date of issuance and will become vested on a ratable basis over a period of 3 years from the date of issuance. Using the Black-Scholes valuation model, we have calculated that the total fair value of these options as of the date of issuance was approximately $342,400, and we will amortize this total amount to stock compensation expense on a straight-line basis over the 3-year vesting period of the options.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 5, 2025, we obtained a two year extension of the maturity date of our $5 million line of credit agreement from the lender to September 3, 2028 (see Note 2).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> false false false false The information required by this item is incorporated by reference to our proxy statement for the 2025 Annual Meeting of Stockholders to be filed with the Securities and Exchange Commission within 120 days of the fiscal year ended June 30, 2025 and is incorporated into this Annual Report on Form 10-K by reference. true